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A sequence variant 
in the diacylglycerol 
O‑acyltransferase 2 gene influences 
palmitoleic acid content in pig 
muscle
Emma Solé, Roger Ros‑Freixedes, Marc Tor, Ramona N. Pena & Joan Estany*
The bulk of body fat in mammals is in the form of triacylglycerol. Diacylglycerol O‑acyltransferase 
2 (DGAT2) catalyses the terminal step in triacylglycerol synthesis. The proximity of DGAT2 with 
stearoyl‑CoA desaturase (SCD) in the endoplasmic reticulum may facilitate provision of de novo 
SCD‑mediated fatty acids as substrate for DGAT2. Here, we first searched for sequence variants 
in the DGAT2 gene to then validate their effect on fat content and fatty acid composition in 
muscle, subcutaneous fat and liver of 1129 Duroc pigs. A single nucleotide polymorphism in exon 
9 (ss7315407085 G > A) was selected as a tag variant for the 33 sequence variants identified in the 
DGAT2 region. The DGAT2‑G allele increased DGAT2 expression in muscle and had a positive impact 
on muscular C14 and C16 fatty acids at the expense of C18 fatty acids. Although there was no evidence 
for an interaction of DGAT2 with functional SCD genotypes, pigs carrying the DGAT2‑G allele had 
proportionally more palmitoleic acid relative to palmitic acid. Our findings indicate that DGAT2 
preferentially uptakes shorter rather than longer‑chain fatty acids as substrate, especially if they are 
monounsaturated, and confirm that fatty acid metabolism in pigs is subjected to subtle tissue‑specific 
genetic regulatory mechanisms.
Abbreviations
BT  Backfat thickness
DGAT  Diacylglycerol O-acyltransferase
GM  Gluteus medius muscle
GWAS  Genome-wide association study
IMF  Intramuscular fat
LM  Longissimus thoracis muscle
LT  Loin thickness
MUFA  Monounsaturated fatty acids
PUFA  Polyunsaturated fatty acids
SCD  Stearoyl-CoA desaturase
SD  Standard deviation
SF  Subcutaneous fat
SFA  Saturated fatty acids
SM  Semimembranosus muscle
SNP  Single nucleotide polymorphism
TG  Triacylglycerols
Meat fat content and composition are important attributes that contribute to the nutritional quality and the 
consumer perception of meat products. Total fat dietary intake, particularly intake of saturated fatty acid (SFA), 
has been associated with obesity, circulating LDL-cholesterol and increased risk of coronary heart  disease1. In 
line with this, public health recommendations advocate for low-fat diets and dietary substitution of SFA with 
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monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA)2–5. On the other hand, although 
most consumers already prefer leaner meat  products6, intramuscular fat (IMF) content and fatty acid composi-
tion exert a great influence on meat organoleptic and technological  properties7,8. Increasing the knowledge of 
the genetic basis of the regulation of fat metabolism is key to improve the quality of meat products.
Triacylglycerols (TG) are the main stores of metabolic energy, serving as a reservoir of essential and non-
essential fatty acids, and the precursors of phospholipids. In mammals, TG are primarily synthesized in the 
liver, intestine and adipose  tissue9. Diacylglycerol O-acyltransferase (DGAT1 and DGAT2) genes are involved in 
intestinal fat absorption and play a critical role in the synthesis of TG in the  adipocytes10,11. In particular, DGAT1 
and DGAT2 encode membrane proteins that catalyse the formation of the ester bond between the hydroxyl 
group of 1,2-diacylglycerol and a long-chain fatty acyl-CoA (Fig. 1)9,12,13, the final step in the production of TG 
in  mammals12–15. Although DGAT1 and DGAT2 have similar functions in the adipocytes, DGAT2 has been 
found to be more critical in mice, where it is essential for post-natal survival and can as well compensate for 
disruptions of  DGAT116–18. Recent findings indicate that DGAT2 is specifically engaged in de novo lipogenesis 
by favouring both the synthesis of TG from glycerol 3-phosphate and the incorporation of endogenous fatty 
acids into TG, particularly the MUFA that result from the desaturation of palmitate (C16:0) and stearate (C18:0) 
through the action of stearoyl-CoA desaturase (SCD)19. DGAT2 and SCD can localize in the endoplasmic reticu-
lum membrane and this proximity may facilitate the provision of de novo SCD-mediated MUFA as substrate 
for DGAT2 to form TG.
Polymorphisms within DGAT2 have the potential of affecting lipogenesis. Thus, DGAT2 has been investi-
gated as a candidate gene for fat-related traits such as obesity in  humans11,20 and for lean content and muscle 
and backfat fatty acid composition in livestock species, particularly in  pigs14,21,22. As a result of a genome-wide 
association study (GWAS) for fatty acid composition in Duroc pigs, we found that the region on SSC9 where 
DGAT2 lies was associated with MUFA content. Here, using this Duroc line as a model, we investigate the role 
of DGAT2 variants on fat metabolism in pigs. We first searched for sequence variants in the promoter, coding, 
and 3′-untranslated regions of porcine DGAT2 and then validated their effect on fat content and composition 
using data and samples from a large  biorepository23. Given that this line segregates for a functional variant in 
the SCD  gene24, potential interactions of DGAT2 with SCD were also assessed.
Materials and methods
Ethics statement. Pigs used in the study were raised and slaughtered in commercial units following appli-
cable regulations and good practice guidelines on the protection of animals kept for farming purposes, during 
transport and slaughter (Royal Decree 37/2014, Spain) and tissue samples used were collected from these pigs 
at the slaughterhouse. In agreement with the European directive 2010/63/UE, tissue sampling from non-experi-
Figure 1.  The role of DGAT2 in the synthesis pathway of triacylglycerol. Triacylglycerol is (1) synthesized 
de novo by sequential addition of fatty acyl moieties to a glycerol 3-phosphate (the G3P pathway) or (2) 
formed through the re-esterification of partial glycerides that results from either the hidrolysis of pre-existing 
triacylglycerol or via the monoacylglycerol (MAG) pathway. De novo transformation of diacylglycerol to 
triacylglycerol is catalyzed by DGAT2 (1) but re-esterification of partial glycerides is done by either DGAT2 (2a) 
or DGAT1 (2b). However, while DGAT1 specifically incorporates pre-formed fatty acids, DGAT2, which is able 
to form protein complexes with MGAT2, FATP1 and SCD, can use both endogenous and pre-formed fatty acids 
as substrates. DGAT1 diacylglycerol O-acyltransferase 1, DGAT2 diacylglycerol O-acyltransferase 2, ELOVL fatty 
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mental animals slaughtered following legal procedures is not under the scope of European regulation on animal 
experimentation and does not require specific project authorization. The experimental protocol was approved 
by the Ethical Committee on Animal Experimentation of the University of Lleida. The study was carried out in 
compliance with the ARRIVE guidelines.
Animals and phenotypes. A total of 1129 pigs from 158 sires and 559 dams of the same Duroc line were 
used in the experiment. Pigs were raised in 15 fattening batches between 2006 and 2016 following a similar pro-
tocol for data recording and tissue  sampling25. In each batch, pigs were raised from 75 days of age until slaughter 
in the same farm under identical conditions. During this period, pigs had ad libitum access to commercial feed 
(Esporc, Riudarenes, Girona, Spain). At 206 (SD 8) days of age, all pigs were weighted and backfat (BT) and loin 
(LT) thickness were ultrasonically measured at 5 cm off the midline between the third and fourth last ribs using 
the portable equipment Piglog 105 (Frontmatec, Kolding, Denmark). Pigs were slaughtered at 211 (SD 9) days 
in a commercial slaughterhouse equipped with a carbon dioxide stunning system. Carcass composition traits 
were recorded, including carcass weight, BT and LT. Both BT and LT were measured at 6 cm off the midline 
between the third and fourth last ribs using an ultrasound automatic scanner (AutoFOM, SFK-Technology, 
Denmark). Immediately after slaughter, a sample of semimembranosus muscle (SM, n = 40) and subcutaneous fat 
(SF, n = 226) were collected, snap-frozen and stored at -80ºC. After chilling for about 24 h at 2 °C, a large sample 
of the muscles gluteus medius (GM, n = 1093) and longissimus thoracis (LM, n = 526) were collected, vacuum 
packaged, and stored at − 20 °C until required. The IMF content in GM and LM, as well as the fatty acid com-
position in GM, LM and SF were determined in duplicate by quantitative gas  chromatography26. The amount 
of each fatty acid was expressed as the percentage of each individual fatty acid relative to total fatty acid. The 
proportion of SFA (C14:0, C16:0, C18:0 and C20:0), MUFA (C16:1n-7, C18:1n-9, C18:1n-7 and C20:1n-9) and 
PUFA (C18:2n-6, C18:3n-3, C20:2n-6 and C20:4n-6) were calculated.
Genome‑wide association study. In order to identify candidate genomic regions associated with fat-
related traits, GWAS for each individual fatty acid were performed using a subset of 254 pigs. The genomic DNA 
of these pigs was isolated as described in Ref.24 and used for single nucleotide polymorphism (SNP) genotyping 
with either the PorcineSNP60 v2 Genotyping BeadChip (n = 138) or the GGP Porcine HD Array (n = 116) por-
cine arrays (Illumina, San Diego, CA, USA). Those SNPs that displayed a minor allele frequency below 0.10, a 
call rate below 0.95, or that could not be mapped to Sus scrofa reference genome (Sscrofa11.1)27 were filtered out. 
A total of 36,000 SNPs remained after data quality control. For each trait, a GWAS was performed by fitting a 
linear mixed model using  GEMMA28, where phenotypes were adjusted for batch (11 levels) and IMF content as 
a covariate. The association of each SNP was tested using the Wald statistic considering the Bonferroni correc-
tion for multiple testing. Significance was set to a level of P ≤ 1.4 ×  10–6. Two regions were found to be associated 
with C16:1n-7, one on SSC9 and another on SSC14, the latter corresponding to a reported polymorphism in the 
SCD gene that is known to affect MUFA and particularly C16:1n-724. Candidate genes mapping within the SSC9 
region were explored with Ensembl Genes Database using BioMart (https:// www. ensem bl. org/ bioma rt/ martv 
iew). Functional analyses like Gene Ontology and Reactome Pathway Enrichment Analysis were performed 
using  Enrichr29. DGAT2 was retrieved as the most promising candidate gene for C16:1n-7 on SSC9.
Sequence variation in DGAT2. Variant discovery in porcine DGAT2 was examined by retrieving all 
sequence variants from the coding region, the 3′-untranslated region and 500 bp upstream on the proximal pro-
moter of the gene (SSC9 10,031,627 to 10,068,464 bp) in a subset of 199 pigs of the same line with whole-genome 
sequencing data available. Sequenced pigs covered all representative sire families used in the experiment. DNA 
samples were submitted to Centre Nacional d’Anàlisi Genòmica (CNAG-CRG, Barcelona, Spain) for sequenc-
ing. Libraries were prepared and sequenced with paired-end reads with a NovaSeq 6000 instrument (Illumina) 
according to the manufacturer’s protocol. Libraries were aligned to the Sscrofa11.127 using the BWA-MEM 
 algorithm30. The average realized sequencing coverage was 6.8x (SD = 1.2×; min = 4.4×; max = 12.2×). Variants 
were identified following GATK HaplotypeCaller 3.8.0  software31,32. The SNP ss7315407085 G > A in exon 9 
(SNP5, 9:10,065,826; Table 1) was selected for further validation with the whole set of pigs.
Genotyping DGAT2. All pigs (n = 1129) used in the experiment were genotyped for SNP ss7315407085 in 
exon 9 of DGAT2 using the primers described in Supplementary Table S1. Amplifications were performed by 
real-time PCR (QuantStudio3, Applied Biosystems, Thermo Scientific, Waltham, MA, USA) with High-Resolu-
tion Melt analysis (Luminaris Colour HRM Master Mix, Thermo Scientific) using 20 ng of genomic DNA and 
0.4 µM of each primer in 5 µL final volume reaction. Thermocycling conditions were 50 °C 2 min, 95 °C 10 min, 
and 40 cycles of 95 °C 15 s, 60 °C 1 min, followed by a high-resolution melting curve starting with a denaturation 
at 95 °C for 15 s, annealing at 60 °C for 1 min and a slow ramp at 0.015 °C/s up to 95 °C. High Resolution Melt 
software v3.1 (Applied Biosystems, Thermo Scientific) was used for melting data analysis and sample genotyp-
ing. All pigs were also genotyped for the SCD (rs80912566 T > C; on SSC14) and leptin receptor (rs709596309 
C > T; on SSC6) SNPs following the protocols described in Refs.24,33, respectively.
DGAT2 expression. DGAT2 expression was measured by quantitative real-time PCR (qPCR) in the SM of 
40 pigs from a single batch. RNA was isolated with TRI-Reagent according to the manufacturer’s protocol and 
purity was assessed by spectrophotometry with a Nanodrop-1000. Total RNA (1.5 µg) was reverse-transcribed 
using SuperScript IV Reverse Transcriptase (Invitrogen, Thermo Scientific) with 100 µM random hexamers at 
23 °C for 10 min, 50 °C for 20 min and 80 °C for 10 min. The cDNA was diluted 1:30 in water. Real-time PCR 
assays were carried out in triplicate using SYBR Green Supermix (Bio-Rad, Hercules, CA, USA), 0.2 µM of each 
4
Vol:.(1234567890)
Scientific Reports |        (2021) 11:14797  | https://doi.org/10.1038/s41598-021-94235-z
www.nature.com/scientificreports/
primer and 3 µl of diluted cDNA. The B2M and RPL32 genes were used as reference genes to quantify and nor-
malize the DGAT2 expression data. Primers used for DGAT2 expression (qDGAT2) are given in Supplementary 
Table S1.
Estimation of DGAT2 tag‑SNP effects. The effect of the DGAT2 ss7315407085 G > A SNP genotypes on 
production traits (body weight, carcass weight, BT and LT) and IMF content and fatty acid composition was esti-
mated using a mixed model that included the batch (15 levels) and the genotype for DGAT2 (GG, AG and AA), 
SCD (TT, CT and CC) and leptin receptor (TT, CT and CC) as fixed effects and the sire and the dam as random 
effects. The leptin receptor polymorphism was included in the model because of its impact on fat content and 
fatty acid  composition33. The slaughter age, for production traits, and IMF content, for fatty acids, were added as 
covariates. The additive and dominant effects of the DGAT2 SNP were estimated by replacing the genotype effect 
with the covariates (1, 0, − 1) and (0, 1, 0) for the GG, AG and AA genotypes, respectively. Gene expression was 
analysed only as a function of the DGAT2 genotype. The effects of the genotype and covariates were tested using 
the F-statistic. Multiple pairwise comparisons among DGAT2 genotypes were tested with the Tukey HSD test. 
Results are presented as least-square means ± standard error. All the analyses were performed using the statistical 
package JMP Pro 14 (SAS Institute Inc., Cary, NC).
Consent for publication. All the authors read and agree to the content of this paper and its publication.
Table 1.  Position, alelles and location of the variants identified in the genomic region from SSC9 10,031,627 
to 10,068,464 bp, which includes coding region, 3′-untranslated region and 500 bp upstream on the proximal 
promoter of the DGAT2 gene. a n: Number of animals genotyped. b MAF: Minor allele frequency.
Variant Position (bp) Location na MAFb Major/minor alleles
SNP1 10,031,901 Promoter 30 0.35 C/A
SNP2 10,032,155 Promoter 97 0.01 T/C
SNP3 10,054,197 Exon 3 183 0.09 C/T
SNP4 10,063,315 Exon 7 179 0.08 A/G
SNP5 10,065,826 Exon 9 120 0.28 G/A
SNP6 10,065,866 3′-UTR 119 0.23 G/A
SNP7 10,066,289 3′-UTR 138 0.49 G/C
SNP8 10,066,329 3′-UTR 142 0.30 C/T
SNP9 10,066,334 3′-UTR 128 0.45 C/T
INDEL10 10,066,364 3′-UTR 141 0.20 CA/C
SNP11 10,066,666 3′-UTR 113 0.18 G/A
INDEL12 10,066,708 3′-UTR 79 0.08 T/TC
INDEL13 10,066,711 3′-UTR 118 0.33 C/CA
INDEL14 10,066,728 3′-UTR 136 0.26 GGA CCT GCT CTT CT/G
SNP15 10,066,750 3′-UTR 127 0.44 C/G
SNP16 10,066,770 3′-UTR 141 0.49 T/A
SNP17 10,066,775 3′-UTR 147 0.41 T/C
SNP18 10,066,885 3′-UTR 158 0.35 T/C
SNP19 10,066,886 3′-UTR 158 0.35 G/A
INDEL20 10,066,928 3′-UTR 157 0.36 CGA/C
SNP21 10,067,012 3′-UTR 156 0.34 A/G
SNP22 10,067,013 3′-UTR 155 0.31 C/T
SNP23 10,067,104 3′-UTR 159 0.03 G/A
INDEL24 10,067,277 3′-UTR 156 0.01 GC/G
SNP25 10,067,474 3′-UTR 144 0.50 A/G
SNP26 10,067,498 3′-UTR 153 0.38 C/A
SNP27 10,067,745 3′-UTR 152 0.28 T/G
SNP28 10,067,850 3′-UTR 158 0.02 G/A
SNP29 10,067,921 3′-UTR 157 0.28 A/G
SNP30 10,068,080 3′-UTR 156 0.31 T/C
SNP31 10,068,240 3′-UTR 156 0.35 A/G
SNP32 10,068,423 3′-UTR 116 0.41 T/C
INDEL33 10,068,438 3′-UTR 96 0.09 CA/C
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Results
The preliminary GWAS revealed two regions associated with C16:1n-7, one on SSC9 and another on SSC14 
(Fig. 2). The region on SSC9 (9.8 Mb to 12.8 Mb) contained 18 significant SNPs (P < 1.4 ×  10–6). Candidate gene 
DGAT2 mapped within this region, specifically at 10.0–10.1 Mb. This association was not identified in previous 
analyses in this Duroc  line32 and evidence for potential implications of sequence variation in DGAT2 on fat 
content and composition in pigs is still very  scarce14,21. On the other hand, the region on SSC14 matched the 
variant in SCD described  above24. No evidence of association was found between the genomic region of DGAT1 
(on SSC4) and fat content and fatty acid composition.
Sequence variation in DGAT2. Using whole-genome sequencing data from pigs of the same line, we 
identified a total of 33 sequence variants in DGAT2. Three of them were exonic, although synonymous (Table 1) 
and, from these, only SNP5 in exon 9 (ss7315407085) had a minor allele frequency greater than 0.25 (0.33). 
With 1000 samples, which are around the current sample size of our biorepository, 0.25 is the minimum minor 
allele frequency required to detect (P < 0.05) a difference of around 5% (0.5 SD) between genotypes for C16:1n-7 
with a power of at least 80%. This SNP has been previously reported in other pig breeds and  crossbreds14,21 and, 
in line with our results, the A allele was the minor allele in all genetic types, with a frequency that ranged from 
0 to 0.32. The other 30 variants were located in the promoter region (2 SNPs) and in the 3′-UTR (21 SNPs and 
7 indels). Using only the sequenced pigs, we confirmed that DGAT2 exerted an additive influence on C16:1n-7 
(Supplementary Table S2), with SNP5 and the sequence variants in the interval between INDEL13 and SNP22 
presenting the most relevant associations. Linkage disequilibrium of all variants was analysed with Haploview 
4.2 software (Supplementary Fig. S1), showing that SNP5 was in linkage disequilibrium with both INDEL13 
 (r2 = 0.51) and SNP22  (r2 = 0.47). In view of these results, we selected SNP5 (ss7315407085) as a tag variant of 
this haplotype for further validation.
Validation of DGAT2 tag SNP. The expression of DGAT2 by ss7315407085 genotype is shown in Fig. 3. 
Despite the limited sample size, the results obtained indicate that the DGAT2-G show a favourable additive effect 
as compared to DGAT2-A on DGAT2 mRNA expression in muscle (+ 0.65 ± 0.27, P < 0.05). The DGAT2-GG 
pigs displayed around 1.5-fold increase in DGAT2 expression compared to the DGAT2-AA pigs (+ 1.48 ± 0.58, 
P < 0.05). Gene expression was measured in SM because it was the only muscle that could be sampled immedi-
ately after slaughter.
The effect of the DGAT2 SNP on fatty acid composition was validated in GM (Table 2) and LM (Table 3) 
using the whole set of pigs in the experiment. In line with preliminary association results in Supplementary 
Table S2, the DGAT2-G allele exerted a positive additive effect on C16:1n-7 in both muscles (+ 0.12% ± 0.03, 
in GM, and + 0.19% ± 0.03, in LM, P < 0.0001). The effect of the DGAT2-G allele had also a positive impact on 
C14:0 (+ 0.04% ± 0.01, in GM, and + 0.05% ± 0.01, in LM, P < 0.01), C16:0 (+ 0.12% ± 0.06, in GM, P = 0.05) and 
C18:1n-7 (+ 0.06% ± 0.02, in GM, P = 0.01). However, the effect of the DGAT2-G allele was proportionally greater 
in C16:1n-7 than in C16:0, as evidenced by subsequent changes in the C16:1n-7 to C16:0 ratio (+ 0.04 ± 0.01, in 
GM, and + 0.07 ± 0.01, in LM, P < 0.01, values × 10). In contrast, the DGAT2-G allele affected negatively C18:0 
and C18:1n-9, particularly in LM (− 0.13% ± 0.06, P < 0.05, and − 0.40% ± 0.15, P < 0.01, respectively).
The DGAT2 SNP did not show dominance effects nor evidence for interaction with the SCD genotype for 
any of the fatty acids. The additive behaviour of the DGAT2-G allele was mantained across all SCD genotypes 
(Fig. 4). Thus, the maximum difference in C16:1n-7, which accounted for around 25% of the mean, occurred 
between the two extreme DGAT2/SCD haplotypes (from 4.05% ± 0.05, for GG/TT, to 3.23% ± 0.08, for AA/CC, 
P < 0.0001). Despite this, the difference between DGAT2-GG and AA genotypes was greater for the SCD-CC 
genotype (+ 0.32% ± 0.09, P < 0.001) than for the SCD-TT genotype (+ 0.15% ± 0.10, P = 0.13).
We did not find evidence of consistent effects of DGAT2 on body weight or carcass fat content (Table 4) or 
on the fatty acid composition of SF (Supplementary Table S3) or liver (Supplementary Table S4). Only a minor 
Figure 2.  Genome-wide associations for palmitoleic acid content in the gluteus medius muscle. Different 
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effect on live body weight was observed (Table 4). Although DGAT2-GG pigs weighted 2.0 kg ± 0.7 (P < 0.05) less 
than DGAT2-AG pigs, the G allele did not show a clear additive behaviour (− 1.0 kg ± 0.6, P = 0.08).
Figure 3.  Relative expression of DGAT2 across ss7315407085 genotypes. Numbers in boxes indicate the 
number of pigs used per genotype (n). Error bars represent standard errors. Columns lacking a common letter 
differ (P < 0.05).
Table 2.  Least square means and additive values (± standard error) for fatty acids content and fatty acid ratios 
in the gluteus medius muscle by DGAT2 genotype. A SFA: saturated fatty acids (C14:0 + C16:0 + C18:0 + C20:0); 
MUFA: monounsaturated fatty acids (C16:1n-7 + C18:1n-9 + C18:1n-7 + C20:1n-9); and PUFA: 
polyunsaturated fatty acids (C18:2n-6 + C18:3n-3 + C20:2n-6 + C20:4n-6). B Additive allele substitution of G for 
A. a,b,c Within trait, means with different superscripts differ significantly (P < 0.05). Bold font indicates statistical 
significance.
TraitA
DGAT2 genotype Additive  valueB
GG (n = 485) AG (n = 482) AA (n = 126) a P-value
Fatty acid, %
C14:0 1.65 ± 0.01a 1.61 ± 0.01b 1.57 ± 0.02b 0.04 ± 0.01 < 0.01
C16:0 23.98 ± 0.06 23.94 ± 0.06 23.74 ± 0.11 0.12 ± 0.06 0.05
C18:0 11.35 ± 0.05b 11.51 ± 0.05a 11.51 ± 0.09a,b − 0.08 ± 0.05 0.10
SFA 37.18 ± 0.10 37.27 ± 0.10 37.04 ± 0.18 0.07 ± 0.10 0.48
C16:1n-7 3.79 ± 0.03a 3.66 ± 0.03b 3.55 ± 0.05c 0.12 ± 0.03 < 0.0001
C18:1n-7 4.79 ± 0.04a 4.74 ± 0.03a,b 4.66 ± 0.05b 0.06 ± 0.02 0.01
C18:1n-9 41.01 ± 0.16 41.27 ± 0.14 41.25 ± .21 − 0.12 ± 0.11 0.29
MUFA 49.52 ± 0.10 49.57 ± 0.10 49.59 ± 0.18 − 0.03 ± 0.10 0.73
C18:2n-6 10.69 ± 0.07 10.62 ± 0.07 10.79 ± 0.12 − 0.06 ± 0.07 0.40
C18:3n-3 0.60 ± 0.005 0.60 ± 0.005 0.61 ± 0.01 − 0.01 ± 0.01 0.23
PUFA 13.29 ± 0.09 13.16 ± 0.09 13.36 ± 0.15 − 0.04 ± 0.08 0.66
Fatty acid ratio
C16:1n-7/C16:0 (× 10) 1.59 ± 0.01a 1.54 ± 0.01b 1.51 ± 0.02b 0.04 ± 0.01 < 0.01
C16:1n-7/C18:1n-9 (× 10) 0.81 ± 0.01c 0.84 ± 0.01b 0.89 ± 0.02a 0.04 ± 0.01 < 0.0001
C18:1n-7/C18:0 (× 10) 4.27 ± 0.06a 4.13 ± 0.05a,b 4.02 ± 0.08b 0.13 ± 0.04 < 0.01
C18:1n-9/C18:0 3.66 ± 0.04 3.60 ± 0.03 3.55 ± 0.05 0.06 ± 0.03 0.06
(C16:1n-7 + C18:1n-7)/C16:0 (× 10) 3.39 ± 0.04a 3.30 ± 0.03b 3.21 ± 0.05b 0.09 ± 0.02 < 0.01
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Discussion
Understanding the regulation of fat metabolism is a milestone in the prevention and treatment of human lipid 
diseases, such as obesity, and in animal science. In this context, DGAT2 has received attention as the enzyme 
that catalyzes the final step in the synthesis of TG, the most common type of body fat. Here, we validated the 
effects of the ss7315407085 G > A SNP on fat content and fatty acid composition as a tag SNP for the haplotype 
in DGAT2 that was identified following a preliminary GWAS and after mRNA expression and sequence vari-
ant association analyses. Using a larger sample, we confirmed that the minor allele A segregates in the studied 
Duroc line at a moderate frequency (0.33), and that it has a negative impact on C16:1n-7 content in muscle. The 
Table 3.  Least square means and additive values (± standard errors) for fatty acids content and fatty acid ratios 
in longissimus dorsi by DGAT2 genotype. A SFA: saturated fatty acids (C14:0 + C16:0 + C18:0 + C20:0); MUFA: 
monounsaturated fatty acids (C16:1n-7 + C18:1n-9 + C18:1n-7 + C20:1n-9); and PUFA: polyunsaturated fatty 
acids (C18:2n-6 + C18:3n-3 + C20:2n-6 + C20:4n-6). B Additive allele substitution of G for A. a,b,c Within trait, 
means with different superscripts differ significantly (P < 0.05). Bold font indicates statistical significance.
TraitA
DGAT2 genotype Additive  valueB
GG (n = 218) AG (n = 238) AA (n = 70) a P-value
Fatty acid, %
C14:0 1.63 ± 0.02a 1.57 ± 0.01b 1.52 ± 0.02b 0.05 ± 0.01 < 0.0001
C16:0 25.07 ± 0.08 25.03 ± 0.08 24.98 ± 0.12 0.05 ± 0.07 0.46
C18:0 12.13 ± 0.07 12.25 ± 0.06 12.38 ± 0.11 − 0.13 ± 0.06 0.04
SFA 39.02 ± 0.13 39.04 ± 0.13 39.08 ± 0.2 − 0.03 ± 0.12 0.80
C16:1n-7 4.04 ± 0.04a 3.88 ± 0.04b 3.67 ± 0.06c 0.19 ± 0.03 < 0.0001
C18:1n-7 4.76 ± 0.04 4.76 ± 0.04 4.67 ± 0.06 0.05 ± 0.03 0.10
C18:1n-9 41.10 ± 0.22b 41.69 ± 0.20a 41.87 ± 0.29a − 0.40 ± 0.15 < 0.01
MUFA 50.29 ± 0.14 50.38 ± 0.13 50.33 ± 0.21 − 0.02 ± 0.12 0.84
C18:2n-6 8.32 ± 0.07 8.26 ± 0.07 8.29 ± 0.11 0.02 ± 0.06 0.78
C18:3n-3 0.37 ± 0.004 0.38 ± 0.004 0.38 ± 0.01 − 0.00 ± 0.00 0.29
PUFA 10.69 ± 0.09 10.58 ± 0.09 10.60 ± 0.15 0.05 ± 0.08 0.57
Fatty acid ratio
C16:1n-7/C16:0 (× 10) 1.62 ± 0.01a 1.55 ± 0.01b 1.47 ± 0.02c 0.07 ± 0.01 < 0.0001
C16:1n-7/C18:1n-9 (× 10) 0.86 ± 0.02c 0.91 ± 0.02b 0.96 ± 0.02a 0.05 ± 0.01 < 0.0001
C18:1n-7/C18:0 (× 10) 4.06 ± 0.07 4.03 ± 0.06 3.91 ± 0.09 0.07 ± 0.05 0.17
C18:1n-9/C18:0 3.47 ± 0.05 3.51 ± 0.04 3.48 ± 0.06 − 0.00 ± 0.04 0.93
(C16:1n-7 + C18:1n-7)/C16:0 (× 10) 3.40 ± 0.04 3.36 ± 0.04 3.27 ± 0.06 0.07 ± 0.03 0.03
Figure 4.  Effect of DGAT2 by SCD genotype on palmitoleic acid (C16:1n-7) in muscle gluteus medius. Numbers 
in boxes indicate the number of pigs used per genotype (n). Error bars represent standard errors. Columns 
lacking a common letter differ (P < 0.05).
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moderate minor allele frequency in the studied Duroc line is similar to estimates from other Duroc  lines14 and 
White and Asian breeds and  crossbreds14,21,22.
Our validation scheme evidenced a consistent effect of DGAT2 SNP on C16:1n-7 in muscle that is independ-
ent of IMF content. A genetic variant in SCD with relevant effects on MUFA also segregates in this  line24. The 
DGAT2 SNP had a lower impact on C16:1n-7 than the SCD SNP variant, particularly in terms of genetic vari-
ance. While the additive value of DGAT2 for C16:1n-7 was around half of that of SCD, the additive variance only 
reached 22% of that attributed to SCD. It has been shown that SCD co-expresses with DGAT234 and that their 
respective enzymes locate very close in the endoplasmic  reticulum11,17, two findings that support the hypoth-
esis that SCD is involved in the TG synthesis by providing a more accessible pool of MUFA through substrate 
 channelling12,17. This also would explain why cells overexpressing DGAT2 show a greater proportion of MUFA 
and very particularly of C16:1n-734. Our results are in line with this hypothesis, because C16:1n-7 was the fatty 
acid most affected by the DGAT2 SNP and the G allele, the one with higher DGAT2 expression, was the one that 
led to accumulate more C16:1n-7. However, we did not find evidence for a positive interaction between SCD and 
DGAT2 SNPs for C16:1n-7. Using RNAseq data from 40 other pigs of the same line, we were able to confirm that 
DGAT2 genotype (GG: n = 19, AG: n = 14, AA: n = 5) affected muscular DGAT2 expression, but we did not detect 
differential expression of SCD by DGAT2 genotype. In absence of interaction, the two genes mostly behaved in 
an allele-dose manner (Fig. 3).
The positive effect of the DGAT2 G allele on C16:1n-7 was not observed on C18:1n-9. Zhang et al.34 evidenced 
that the impact of DGAT2 on C16:1n-7 was proportionally greater as fatty acid composition turned more depend-
ent on de novo fatty acids. For C18:1n-9, the same effect was only seen in mature adipocytes, especially when they 
were cultured in a fatty acid-rich medium. In line with these results, a plausible explanation to the differential 
trend between C16:1n-7 and C18:1n-9 could be that the most immediate (short-term) effect of DGAT2 is to alter 
fatty acid composition by selectively capturing as substrate the first available de novo fatty acids rather than to 
enhance the endogenous biosynthesis of longer-chain fatty acids. This may be the case here, since differences in 
DGAT2 expression across genotypes were relatively small and no correlated responses in IMF content and SCD 
expression were observed. The favourable effect of the G allele on C14 and C16 fatty acids would reinforce this 
hypothesis. On the other hand, the impact of de novo fatty acids on final fatty acid composition is more apparent 
in C16:1n-7 and C18:1n-7 than in C18:1n-9, which is proportionally more abundant in pig feed than C16:1n-7 
and thus more likely to be influenced by the diet. Similarly, the effect of DGAT2 on fatty acid composition was 
only observed in IMF, which is precisely the adipose tissue that develops  later35 and is less sensitive to dietary  fat36.
Changes in DGAT2 expression are related to lipid accumulation. Results in human and murine cells indicate 
that DGAT2 promotes TG synthesis and storage in cytosolic lipid  droplets37 and accordingly DGAT2 is expressed 
more abundantly in cells with greater de novo fatty acid  synthesis19. This is in line with findings in pigs, in which 
DGAT2 was most expressed in the liver of fatter breeds, where TG are expected to be more actively  synthesized38. 
The expression of DGAT2 was twofold higher in fatter than in leaner breeds and around fivefold and tenfold 
higher in liver than in subcutaneous fat and muscle, respectively. However, the mRNA expression of DGAT2 was 
positively correlated with IMF content but not with BT. In view of these results, it would appear that the pigs car-
rying the DGAT2 A allele, which down-regulates the expression of DGAT2, should be less fatty and, specifically, 
have less IMF content. Even though this association was reported in other  studies14,21, we did not find evidence 
that DGAT2 A entails a reduction in IMF content, BT or even fat content in liver. This may contradict biologi-
cal expectations, but, in comparison with previous reports, validation here was performed using a much larger 
set of pigs from a single line so as to avoid breed or family biases. A 13-bp deletion in DGAT2 3′-UTR region 
has also been associated with increased DGAT2 mRNA expression and  BT39. This deletion allele showed higher 
transcriptional activity, most likely owing to a less stable 3′-UTR secondary structure. This indel was located at 
905 bp downstream from the stop codon and matches INDEL14 (Table 1). In line with the results observed for 
Table 4.  Least square means and additive values (± standard error) for body weight (BW), carcass weight 
(CW), backfat (BT) and loin (LT) thickness and intramuscular fat (IMF) content by DGAT2 genotype. 
A Additive allele substitution of G for A. a,b Within trait, means with different superscripts differ significantly 
(P < 0.05).
Trait
DGAT2 genotype Additive  valueA
GG (n = 496) AG (n = 488) AA (n = 129) a P-value
Live measurements
BW, kg 124.3 ± 0.6b 126.3 ± 0.6a 126.4 ± 1.1a,b − 1.0 ± 0.6 0.08
BT, mm 21.9 ± 0.2 22.1 ± 0.2 22.4 ± 0.4 − 0.3 ± 0.2 0.20
LT, mm 47.5 ± 0.3 47.1 ± 0.3 47.7 ± 0.5 − 0.1 ± 0.3 0.83
Carcass measurements
CW, kg 96.0 ± 0.5 97.4 ± 0.5 97.1 ± 0.9 − 0.6 ± 0.5 0.24
BT, mm 25.6 ± 0.2 26.0 ± 0.2 26.4 ± 0.4 − 0.4 ± 0.2 0.08
LT, mm 44.1 ± 0.4 43.8 ± 0.4 43.8 ± 0.7 0.1 ± 0.4 0.74
IMF content, % dry matter
M. gluteus medius 18.1 ± 0.3 17.6 ± 0.3 18.1 ± 0.5 − 0.02 ± 0.03 0.94
M. longissimus thoracis 13.3 ± 0.3 13.5 ± 0.3 13.0 ± 0.4 0.16 ± 0.23 0.48
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SNP5, none of these polymorphisms including INDEL14  (r2 = 0.57, Supplementary Fig. S1) affected BT in our 
Duroc line (Supplementary Table S2).
The results obtained are more appealing for lipid research than for pig breeding. In recent years, C16:1n-7 
has received a lot of attention for its potential role as a lipokine, i.e. as a lipid hormone that acts in distant organs. 
Despite this, the effects of C16:1n-7 are still under debate. On the one hand, preclinical experiments with cell and 
rodent models show that C16:1n-7 supplementation has anti-inflammatory  properties40,41 that protect against 
metabolic disorders. But, on the other hand, research in humans reported elevated blood levels of C16:1n-7 in 
patients with obesity and metabolic  syndrome42,43. Findings in pigs may contribute to disentangle the biological 
implications of C16:1n-7 as well as to understand the genetic regulation of fat metabolism.
Conclusions
A sequence variant in the porcine DGAT2 influences muscular gene expression and fatty acid composition, with 
changes mostly limited to swapping C18 fatty acids for C14 and C16 fatty acids of the same degree of saturation. 
Differences across DGAT2 genotypes are quantitatively small, but the variant that enhances DGAT2 expression 
is associated with increased content of shorter-chain fatty acids, thereby indicating that DGAT2 preferentially 
uptakes the first available de novo fatty acids as substrate. Although DGAT2 and SCD act additively, the fact that 
DGAT2 overexpression impacts C16:1n-7 more than C16:0 indicates that DGAT2 and SCD are closely interlinked. 
Further enzyme characterization is needed, but our findings provide evidence that C16:1n-7 is the immediate 
substrate for DGAT2 and corroborate that fatty acid metabolism in pigs is subjected to subtle tissue-specific 
genetic regulatory mechanisms.
Data availability
Data that support the findings of this study are available within the article and Supplementary Information, or 
from the authors upon reasonable request.
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